SOMERSET, N.J., Feb. 10, 2009 (GLOBE NEWSWIRE) -- Ventiv Professional Development Group (PDG), an inVentiv Health company (Nasdaq:VTIV), today announced that Stiefel Laboratories, Inc., the world's largest independent pharmaceutical company specializing in dermatology, is partnering with PDG to extend its global selling skills platform into several new markets.
PDG has worked with Stiefel over the past two years to develop and implement a customized selling skills platform based on PDG's proprietary RxAdvantage product. The platform was initially launched to Stiefel's sales teams in the United States and Asia Pacific countries in 2007. Based on the success of the program, Stiefel is now partnering with PDG to extend it to Latin and South America and Great Britain, and is planning a pilot program for the rest of Europe.
"Stiefel's customer-focused sales approach is an integral part of our brand and our culture. Through our partnership with PDG, we have taken steps to ensure that our core values and principles are understood and upheld by our sales teams around the world. The platform that PDG designed for us has helped establish a strong global identity for Stiefel and its products, while at the same time providing the flexibility to customize materials and other components of the program to the unique needs of the local markets," said Rick Goukler, Executive Director of Training and Development at Stiefel Laboratories, Inc.
"Stiefel has built a very strong sales organization across the globe -- and it has been a thrill for us to partner with them on the design and implementation of their selling skills platform," said Warren Odette, Managing Director, Ventiv Professional Development Group. "We're very pleased that the platform we developed for Stiefel is supporting their global strategic objectives and helping to strengthen their brand domestically and around the world."
About Stiefel
Stiefel Laboratories is enthusiastically committed to advancing dermatology and skin science around the world. The company's deeply-rooted dedication and drive for innovation along with its sole focus on dermatology has led Stiefel to become the largest independent dermatology company in the world. In addition to more than 30 wholly-owned subsidiaries, six manufacturing plants and a global research and development network, Stiefel's most valuable asset is its global network of nearly 4,000 driven associates.
By combining expertise, knowledge and imagination, Stiefel delivers exceptional ethical, over-the-counter and aesthetic products to its customers in more than 100 countries around the world, ultimately providing a unique Stiefel skin health experience. Stiefel also is committed to improving today's treatments and exploring tomorrow's innovations. Each year, the company invests more than $100 million USD in developing the most advanced skin health solutions. Additionally, Stiefel supplements its research and development efforts by seeking strategic partnerships and acquisitions around the world. To learn more about Stiefel, visit www.stiefel.com.
About Ventiv Professional Development Group
With a focus on the pharmaceutical and life sciences industries, Ventiv Professional Development Group uses a combination of self-paced, on-site classroom, training center and distance learning tools to help clients enhance the performance of their sales representatives. PDG's flexible, client-centric training solutions range from initial skill assessments to specialized skill-set training and development, to delivery of customized curriculums.
About inVentiv Health
inVentiv Health, Inc. (Nasdaq:VTIV) is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 350 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit www.inventivhealth.com.
The inVentiv Health, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4942
Forward-Looking Information
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation, the potential impact of a recessionary environment on our customers and business; the possibility that customer agreements will be terminated or not renewed; our ability to grow our existing client relationships, obtain new clients and cross-sell our services; and changes in trends in the pharmaceutical industries or in pharmaceutical outsourcing. Readers of this press release are referred to documents filed from time to time by inVentiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors.